Literature DB >> 19255466

Cloning, purification, crystallization and preliminary X-ray analysis of a chimeric NADPH-cytochrome P450 reductase.

Louise Aigrain1, Denis Pompon, Gilles Truan, Solange Moréra.   

Abstract

NADPH-cytochrome P450 reductase (CPR) is the favoured redox partner of microsomal cytochromes P450. This protein is composed of two flavin-containing domains (FMN and FAD) connected by a structured linker. An active CPR chimera consisting of the yeast FMN and human FAD domains has been produced, purified and crystallized. The crystals belonged to the monoclinic space group C2 and contained one molecule per asymmetric unit. Molecular replacement was performed using the published rat and yeast structures as search models. The initial electron-density maps revealed that the chimeric enzyme had crystallized in a conformation that differed from those of previously solved structures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255466      PMCID: PMC2650470          DOI: 10.1107/S1744309109000700

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  9 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

Review 2.  Electron transfer by diflavin reductases.

Authors:  Marat B Murataliev; René Feyereisen; F Ann Walker
Journal:  Biochim Biophys Acta       Date:  2004-04-08

3.  Likelihood-enhanced fast rotation functions.

Authors:  Laurent C Storoni; Airlie J McCoy; Randy J Read
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-02-25

4.  A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases.

Authors:  David C Lamb; Youngchang Kim; Liudmila V Yermalitskaya; Valery N Yermalitsky; Galina I Lepesheva; Steven L Kelly; Michael R Waterman; Larissa M Podust
Journal:  Structure       Date:  2006-01       Impact factor: 5.006

5.  Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.

Authors:  A Gutierrez; L Y Lian; C R Wolf; N S Scrutton; G C Roberts
Journal:  Biochemistry       Date:  2001-02-20       Impact factor: 3.162

6.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

7.  Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains.

Authors:  G C Smith; D G Tew; C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

8.  Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes.

Authors:  M Wang; D L Roberts; R Paschke; T M Shea; B S Masters; J J Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

9.  Mechanism of cytochrome P450 reductase from the house fly: evidence for an FMN semiquinone as electron donor.

Authors:  M B Murataliev; R Feyereisen
Journal:  FEBS Lett       Date:  1999-06-18       Impact factor: 4.124

  9 in total
  1 in total

1.  NADPH-cytochrome P450 reductase: molecular cloning and functional characterization of two paralogs from Withania somnifera (L.) dunal.

Authors:  Satiander Rana; Surrinder K Lattoo; Niha Dhar; Sumeer Razdan; Wajid Waheed Bhat; Rekha S Dhar; Ram Vishwakarma
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.